AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Clover Health Investments Corp (NASDAQ:CLOV)
3.51 USD
-0.190 5.135%Sponsored Reports
Loading...
| Previous Close (in USD) | 3.7 |
|---|---|
| Change | -0.190 5.135% |
| 52 W H/L (in USD) | 4.710/0.606 |
| EBITDA (in USD) | -77.085M |
| PE Ratio | -- |
| Volume | 3824928 |
| Diluted Eps TTM | -0.19 |
| Total Assets (in USD) | 570.671M |
|---|---|
| Total Liabilities (in USD) | 284.277M |
| Revenue TTM (in USD) | 2115.22M |
| Cash (in USD) | 122.863M |
| Market Cap (in USD) | 1,653.659 M |
| Revenue Per Share TTM | 4.336 |
| Gross Profit TTM (in USD) | 126.192M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Clover Health Investments Corp
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.
Employees: 552
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Vivek Garipalli | Co-Founder, CEO & Chairman of Directors | 1979 |
| 2. | Mr. Andrew Toy | Co-Founder, Pres, & Director | 1979 |
| 3. | Ms. Jamie L. Reynoso | Chief Operating Officer | 1970 |
| 4. | Mr. Prabhdeep Singh | Chief Growth Officer | 1985 |
| 5. | Mr. Scott J. Leffler | Chief Financial Officer | 1975 |
| 6. | Mr. Conrad Wai | Chief Technology Officer | NA |
| 7. | Mr. Derrick L. Nueman | Head of Investor Relations & Corp. strategy | NA |
| 8. | Ms. Wendy Richey | Chief Compliance Officer | NA |
| 9. | Mr. Joseph Richards Martin | Gen. Counsel & Corp. Sec. | 1977 |
| 10. | Ms. Rachel Fish | Chief People Officer | NA |
Peers
Sector: Healthcare
Industry: Healthcare Plans
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
UNH
UnitedHealth Group Incorporated |
+2.050 0.398% | 516.87 | 22.570 | 18.382 | 1.326 | 5.648 | 1.379 | 13.969 |
|
ELV
Elevance Health Inc |
+2.845 0.659% | 436.29 | 18.000 | 12.658 | 0.653 | 2.865 | 0.735 | 0.000 |
|
CVS
CVS Health Corp |
-0.910 1.346% | 67.7 | 12.060 | 9.083 | 0.287 | 1.337 | 0.470 | 8.959 |
|
CI
Cigna Corp |
+0.610 0.188% | 325.79 | 30.250 | 10.091 | 0.386 | 2.100 | 0.502 | 0.000 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | -338.844M | -587.756M | -91.582M | -363.737M | - |
| Minority Interest | - | - | 3.903M | 3.903M | 3.903M |
| Net Income | -305.401M | -604.666M | -148.69M | -402.805M | - |
| Selling General Administrative | 486.642M | 445.745M | 191.7M | 187.327M | - |
| Gross Profit | 22.735M | -79.182M | 82.42M | 12.565M | - |
| Reconciled Depreciation | 1.187M | 1.246M | 0.555M | 0.551M | - |
| Ebit | -370.924M | -636.992M | -92.707M | -183.199M | -185.797M |
| Ebitda | -369.737M | -635.746M | -92.152M | -182.648M | - |
| Depreciation And Amortization | 1.187M | 1.246M | 0.555M | 0.551M | - |
| Operating Income | -370.924M | -636.992M | -92.707M | -183.199M | - |
| Other Operating Expenses | 3847.611M | 2108.988M | 765.595M | 645.465M | 0.34M |
| Interest Expense | 1.363M | 16.91M | 57.108M | 39.068M | 0M |
| Tax Provision | - | - | - | - | - |
| Interest Income | - | - | 0.117M | - | - |
| Net Interest Income | -1.363M | -16.91M | -57.108M | -39.068M | - |
| Income Tax Expense | -33.443M | 16.91M | 57.108M | 39.068M | - |
| Total Revenue | 3476.687M | 1471.996M | 672.888M | 462.266M | - |
| Total Operating Expenses | 393.659M | 557.81M | 175.127M | 195.764M | - |
| Cost Of Revenue | 3453.952M | 1551.178M | 590.468M | 449.701M | - |
| Total Other Income Expense Net | 32.08M | 49.236M | 1.125M | -180.538M | - |
| Net Income From Continuing Ops | -338.844M | -587.756M | -91.582M | -363.737M | - |
| Net Income Applicable To Common Shares | -338.844M | -587.756M | -136.392M | -363.737M | -201.928M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 570.671M | 808.62M | 950.804M | 267.252M | 0.1M |
| Intangible Assets | 2.99M | - | - | - | - |
| Other Current Assets | 1.404M | 24.43M | 52.945M | 0.3M | 2.173M |
| Total Liab | 284.277M | 460.882M | 411.487M | 835.635M | 0.118M |
| Total Stockholder Equity | 286.394M | 347.738M | 539.317M | -568.383M | -0.018M |
| Other Current Liab | 80.574M | 406.384M | 175.568M | 33.128M | 0.118M |
| Common Stock | 0.049M | 0.046M | 0.046M | 788.509M | 0.004M |
| Capital Stock | 0.049M | 0.046M | 0.046M | 788.509M | - |
| Retained Earnings | -2159.794M | -1955.582M | -1616.738M | -6.762M | -0.018M |
| Good Will | 0M | - | - | - | - |
| Other Assets | - | 15.735M | 950.804M | -589.168M | 9.704M |
| Cash | 122.863M | 103.791M | 299.968M | 28.003M | 0M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 261.115M | 440.656M | 372.624M | 33.934M | 0.118M |
| Current Deferred Revenue | 141.692M | - | 165.868M | - | - |
| Net Debt | -118.2M | -97.931M | -272.141M | -27.197M | - |
| Short Term Debt | 1.665M | 1.827M | 3.059M | 0.806M | - |
| Short Long Term Debt | - | - | - | 0.806M | - |
| Short Long Term Debt Total | 4.663M | 5.86M | 27.827M | 0.806M | - |
| Other Stockholder Equity | 2132.309M | 1917.579M | 1541.906M | -1350.129M | 0.046M |
| Property Plant Equipment | - | 9.778M | 7.654M | 9.96M | 13.037M |
| Total Current Assets | 427.97M | 624.997M | 752.546M | 28.303M | 252.956M |
| Long Term Investments | 121.001M | 138.11M | 175.939M | - | - |
| Short Term Investments | 119.822M | 230.97M | 315.287M | 123.1M | - |
| Net Receivables | 113.832M | 147.158M | 62.324M | 84.942M | 44.547M |
| Long Term Debt | - | - | 19.938M | - | - |
| Inventory | 70.049M | -101.884M | -153.917M | - | - |
| Accounts Payable | 37.184M | 32.445M | 28.129M | 134.647M | 114.84M |
| Accumulated Other Comprehensive Income | -2.37M | -9.374M | -1.934M | - | - |
| Non Currrent Assets Other | 10.246M | 15.735M | 10.432M | 828.117M | 0.1M |
| Non Current Assets Total | 142.701M | 183.623M | 198.258M | 828.117M | 0.1M |
| Capital Lease Obligations | 4.663M | 5.86M | 7.889M | - | - |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | 95.133M | -434.724M | 138.097M | -180.705M | 99.001M |
| Total Cashflows From Investing Activities | 95.133M | -435.447M | 137.404M | -181.908M | 97.525M |
| Total Cash From Financing Activities | -4.962M | 925.393M | 858.23M | 333.978M | 74.589M |
| Net Income | -338.844M | -587.756M | -6.745M | -363.737M | -201.928M |
| Change In Cash | -113.755M | 207.62M | 28.003M | -7.805M | 18.832M |
| Begin Period Cash Flow | 299.968M | 92.348M | 67.598M | 75.403M | - |
| End Period Cash Flow | 186.213M | 299.968M | 28.003M | 67.598M | 75.403M |
| Total Cash From Operating Activities | -203.926M | -282.326M | -2.227M | -159.875M | -153.282M |
| Depreciation | 1.187M | 1.246M | 0.555M | 0.551M | 0.487M |
| Other Cashflows From Investing Activities | - | - | - | - | - |
| Dividends Paid | - | 0.305M | - | - | - |
| Change To Inventory | - | - | - | - | - |
| Sale Purchase Of Stock | -6.362M | -0.147M | - | 0M | - |
| Other Cashflows From Financing Activities | 95.133M | 666.851M | 44.905M | 343.047M | -0.541M |
| Capital Expenditures | 4.467M | 0.723M | 0.693M | 0.023M | 1.476M |
| Change In Working Capital | 98.315M | 192.673M | 4.635M | 32.307M | - |
| Other Non Cash Items | -128.889M | 13.881M | -0.117M | 24.689M | - |
| Free Cash Flow | -208.393M | -283.049M | -2.227M | -159.898M | - |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Total Stock Mkt Idx Inv | 4 months ago | 10958820 |
| 2. | Vanguard Institutional Extnd Mkt Idx Tr | 4 months ago | 6055118 |
| 3. | Fidelity Extended Market Index | 4 months ago | 2255807 |
| 4. | Schwab US Small-Cap ETF™ | 3 months ago | 1984921 |
| 5. | Invesco FTSE RAFI US 1500 Small-Mid ETF | 4 months ago | 1374823 |
| 6. | Vanguard Health Care ETF | 4 months ago | 1282813 |
| 7. | BlackRock Extended Equity Market K | 5 months ago | 845640 |
| 8. | Fidelity Total Market Index | 4 months ago | 741729 |
| 9. | Avantis US Small Cap Equity ETF | 3 months ago | 661323 |
| 10. | Fidelity Series Total Market Index | 4 months ago | 557588 |
| 11. | iShares Core S&P Total US Stock Mkt ETF | 3 months ago | 529477 |
| 12. | Schwab Fundamental U.S. Small CompanyETF | 3 months ago | 507750 |
| 13. | iShares US Healthcare Providers ETF | 3 months ago | 491897 |
| 14. | NT Ext Equity Mkt Idx Fd - L | 5 months ago | 416414 |
| 15. | Northern Trust Extended Eq Market Idx | 5 months ago | 416414 |
| 16. | NT Ext Equity Mkt Idx Fd - NL | 5 months ago | 392328 |
| 17. | NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 5 months ago | 316099 |
| 18. | SPDR® S&P Health Care Services ETF | 4 months ago | 313027 |
| 19. | Spartan Extended Market Index Pool E | 4 months ago | 297717 |
| 20. | Spartan Total Market Index Pool E | 4 months ago | 252953 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Group Inc | 5 months ago | 19198714 |
| 2. | Renaissance Technologies Corp | 5 months ago | 12479900 |
| 3. | BlackRock Inc | 8 months ago | 9539168 |
| 4. | Susquehanna International Group, LLP | 5 months ago | 1879198 |
| 5. | Two Sigma Investments LLC | 5 months ago | 1638951 |
| 6. | Morgan Stanley - Brokerage Accounts | 5 months ago | 1514223 |
| 7. | Tudor Investment Corp Et AL | 5 months ago | 1462558 |
| 8. | Marshall Wace Asset Management Ltd | 5 months ago | 1408863 |
| 9. | Amvescap Plc. | 5 months ago | 1396640 |
| 10. | GMT Capital Corp | 5 months ago | 1305200 |
| 11. | Jane Street Group LLC | 8 months ago | 1200333 |
| 12. | Connor Clark & Lunn Inv Mgmt Ltd | 5 months ago | 1128171 |
| 13. | Northern Trust Corp | 5 months ago | 935912 |
| 14. | Swiss National Bank | 5 months ago | 754400 |
| 15. | Goldman Sachs Group Inc | 5 months ago | 500281 |
| 16. | Geode Capital Management, LLC | 5 months ago | 4828701 |
| 17. | PNC Financial Services Group Inc | 5 months ago | 4810668 |
| 18. | Charles Schwab Investment Management Inc | 5 months ago | 3000505 |
| 19. | Qube Research & Technologies | 5 months ago | 2758636 |
| 20. | State Street Corp | 5 months ago | 2189380 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Related Articles
Loading...
